<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10652927258032</udiDi>
    <basicUdiDi>B-10652927258032</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO285017B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:23.712Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927263487</udiDi>
    <basicUdiDi>B-10652927263487</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284019F4P</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:22.444Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927230076</udiDi>
    <basicUdiDi>B-10652927230076</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO580148BI0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:05.378Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927206811</udiDi>
    <basicUdiDi>B-10652927206811</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284022B0P</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:55:29.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927796398</udiDi>
    <basicUdiDi>B-10652927796398</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280137B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:35:46.632Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927727460</udiDi>
    <basicUdiDi>B-10652927727460</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282037B6P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:35:41.226Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927718918</udiDi>
    <basicUdiDi>B-10652927718918</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282065Ax20P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:35:18.989Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927718901</udiDi>
    <basicUdiDi>B-10652927718901</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282024F2P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:35:18.174Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927697374</udiDi>
    <basicUdiDi>B-10652927697374</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280165B0P</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:35:17.369Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927389552</udiDi>
    <basicUdiDi>B-10652927389552</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282031B0P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:59.877Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927357605</udiDi>
    <basicUdiDi>B-10652927357605</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283016F4P</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:55.753Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927321491</udiDi>
    <basicUdiDi>B-10652927321491</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283019B0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:54.177Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927307853</udiDi>
    <basicUdiDi>B-10652927307853</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283024F4P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:42.994Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287131</udiDi>
    <basicUdiDi>B-10652927287131</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283019F13M</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:42.948Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927300731</udiDi>
    <basicUdiDi>B-10652927300731</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282024F4P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:42.183Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287094</udiDi>
    <basicUdiDi>B-10652927287094</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283017B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:38.214Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286981</udiDi>
    <basicUdiDi>B-10652927286981</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282036B6P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:37.379Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287155</udiDi>
    <basicUdiDi>B-10652927287155</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283022B0P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:36.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286882</udiDi>
    <basicUdiDi>B-10652927286882</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282030F4P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:19.670Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286868</udiDi>
    <basicUdiDi>B-10652927286868</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO282026H0P</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-23T21:34:18.837Z</lastUpdated>
  </row>
</eudamedExport>